Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
University of Lille, INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, Hôpital Claude Huriez, CERAINOM, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
Chest. 2024 Oct;166(4):837-844. doi: 10.1016/j.chest.2024.05.010. Epub 2024 Jun 6.
The 2022 European Society of Cardiology/European Respiratory Society guidelines define pulmonary hypertension (PH) as a resting mean pulmonary artery pressure (mPAP) > 20 mm Hg at right heart catheterization (RHC). Previously, patients with an mPAP between 21 and 24 mm Hg were classified in a "gray zone" of unclear clinical significance.
What is the diagnostic performance of the main parameters used for PH screening in detecting patients with systemic sclerosis (SSc) with an mPAP of 21 to 24 mm Hg at RHC?
Patients with SSc from the European Scleroderma Trials and Research (EUSTAR) database with available tricuspid annular plane systolic excursion (TAPSE), systolic PAP (sPAP), and mPAP data were included. Patients with mPAP 21 to 24 mm Hg and patients with mPAP ≤ 20 mm Hg were considered for the analysis. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated.
TAPSE/sPAP was lower in the group of patients with SSc with mPAP 21 to 24 mm Hg than in the non-PH group (0.58 [0.46-0.72] vs 0.69 [0.57-0.81] mm/mm Hg, respectively; P < .01). No difference was found in other parameters between the two groups. Diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value had the highest sensitivity (88.9%) and NPV (80%), but the lowest specificity (18.2%) and PPV (30.8%) in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity (78.9%), PPV (50%), and accuracy (68.1%); its NPV was 75.4%, and its sensitivity was 45.1%.
In this study, diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value was the parameter with the highest sensitivity and NPV in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity, PPV, and accuracy and, therefore, can be a useful additional parameter to decrease the number of unnecessary RHCs.
2022 年欧洲心脏病学会/欧洲呼吸学会指南将静息状态下平均肺动脉压(mPAP)>20mmHg 定义为肺动脉高压(PH)。在此之前,mPAP 在 21-24mmHg 之间的患者被归类为临床意义不明确的“灰色地带”。
用于 PH 筛查的主要参数在检测接受右心导管检查(RHC)的系统性硬化症(SSc)患者中 mPAP 在 21 至 24mmHg 时的诊断性能如何?
纳入了欧洲硬皮病试验和研究(EUSTAR)数据库中具有三尖瓣环平面收缩期位移(TAPSE)、收缩期肺动脉压(sPAP)和 mPAP 数据的 SSc 患者。分析了 mPAP 在 21 至 24mmHg 和 mPAP≤20mmHg 的患者。计算了灵敏度、特异性、阳性预测值(PPV)、阴性预测值(NPV)和准确性。
mPAP 在 21 至 24mmHg 的 SSc 患者组的 TAPSE/sPAP 低于非 PH 组(分别为 0.58[0.46-0.72] vs 0.69[0.57-0.81]mm/mm Hg;P<0.01)。两组间其他参数无差异。一氧化碳弥散量<80%预计值在检测 mPAP 在 21 至 24mmHg 的 SSc 患者时具有最高的灵敏度(88.9%)和 NPV(80%),但特异性(18.2%)和 PPV(30.8%)最低。TAPSE/sPAP<0.55mm/mm Hg 的特异性(78.9%)、PPV(50%)和准确性(68.1%)最高;NPV 为 75.4%,灵敏度为 45.1%。
在这项研究中,一氧化碳弥散量<80%预计值是检测 mPAP 在 21 至 24mmHg 的 SSc 患者时具有最高灵敏度和 NPV 的参数。TAPSE/sPAP<0.55mm/mm Hg 的特异性、PPV 和准确性最高,因此可以作为减少不必要 RHC 的有用附加参数。